This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schreiber, M. Articles by Schneider-Mergener, J. Search for Related Content PubMed PubMed Citation Articles by Schreiber, M. Articles by Schneider-Mergener, J.

 Previous Article  |  Next Article 

J. Virol., 12 1997, 9198-9205, Vol 71, No. 12
Copyright © 1997, American Society for Microbiology

The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain

M Schreiber, C Wachsmuth, H Muller, S Odemuyiwa, H Schmitz, S Meyer, B Meyer and J Schneider-Mergener
Medical Microbiology Section, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. mschreib@sgi1.chemie.uni-hamburg.de

The specific binding of antibodies to the V3 loop in sera from human immunodeficiency type 1 (HIV-1)-infected individuals was investigated. Different V3 structures were analyzed as full-length loops or by pepscan. Our data show that on full-length V3 loops, both variable regions on either side of the tip of the loop (GPGRAF) contribute to a common epitope for type-specific antibodies. Type-specific antibodies bound strongly and at high titers to native V3 loops but negligibly once the loop was denatured. In contrast to the type-specific, discontinuous epitope, the linear, conserved epitopes presented by the full-length V3 loop, the tip, the amino-terminal base, and the carboxy- terminal base were not accessible to serum antibody. When the V3 sequences were analyzed with linear peptides, antibodies bound preferentially to peptides containing the conserved GPGRAF sequence. Thus, two different specificities of V3-directed antibodies were detected in patient sera. Unlike group-specific antibodies directed against GPGRAF peptides, lack of type-specific antibodies directed against the discontinuous epitope was correlated with viral escape from autologous neutralization. Our data suggest that the full-length conformation of the V3 loop is accessible predominantly to highly type- specific antibodies present in sera from HIV-1-infected individuals. These antibodies are directed against discontinuous V3 epitopes, not against conserved linear V3 targets. The implications of these findings for viral escape and blockade of infection with V3-based vaccines are discussed.

This article has been cited by other articles:

• Krachmarov, C., Pinter, A., Honnen, W. J., Gorny, M. K., Nyambi, P. N., Zolla-Pazner, S., Kayman, S. C. (2005). Antibodies That Are Cross-Reactive for Human Immunodeficiency Virus Type 1 Clade A and Clade B V3 Domains Are Common in Patient Sera from Cameroon, but Their Neutralization Activity Is Usually Restricted by Epitope Masking. J. Virol. 79: 780-790 [Abstract] [Full Text]  
• Yang, Z.-y., Chakrabarti, B. K., Xu, L., Welcher, B., Kong, W.-p., Leung, K., Panet, A., Mascola, J. R., Nabel, G. J. (2004). Selective Modification of Variable Loops Alters Tropism and Enhances Immunogenicity of Human Immunodeficiency Virus Type 1 Envelope. J. Virol. 78: 4029-4036 [Abstract] [Full Text]  
• Gorny, M. K., Williams, C., Volsky, B., Revesz, K., Cohen, S., Polonis, V. R., Honnen, W. J., Kayman, S. C., Krachmarov, C., Pinter, A., Zolla-Pazner, S. (2002). Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades. J. Virol. 76: 9035-9045 [Abstract] [Full Text]  
• Hofmann-Lehmann, R., Vlasak, J., Chenine, A.-L., Li, P.-L., Baba, T. W., Montefiori, D. C., McClure, H. M., Anderson, D. C., Ruprecht, R. M. (2002). Molecular Evolution of Human Immunodeficiency Virus env in Humans and Monkeys: Similar Patterns Occur during Natural Disease Progression or Rapid Virus Passage. J. Virol. 76: 5278-5284 [Abstract] [Full Text]  
• Chen, C.-H., Jin, L., Zhu, C., Holz-Smith, S., Matthews, T. J. (2001). Induction and Characterization of Neutralizing Antibodies against a Human Immunodeficiency Virus Type 1 Primary Isolate. J. Virol. 75: 6700-6704 [Abstract] [Full Text]  
• Nyambi, P. N., Nádas, A., Mbah, H. A., Burda, S., Williams, C., Gorny, M. K., Zolla-Pazner, S. (2000). Immunoreactivity of Intact Virions of Human Immunodeficiency Virus Type 1 (HIV-1) Reveals the Existence of Fewer HIV-1 Immunotypes than Genotypes. J. Virol. 74: 10670-10680 [Abstract] [Full Text]  
• Wobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., Kleinschmidt, J. A. (2000). Monoclonal Antibodies against the Adeno-Associated Virus Type 2 (AAV-2) Capsid: Epitope Mapping and Identification of Capsid Domains Involved in AAV-2-Cell Interaction and Neutralization of AAV-2 Infection. J. Virol. 74: 9281-9293 [Abstract] [Full Text]  
• Skraban, R., Matthiasdottir, S., Torsteinsdottir, S., Agnarsdottir, G., Gudmundsson, B., Georgsson, G., Meloen, R. H., Andresson, O. S., Staskus, K. A., Thormar, H., Andresdottir, V. (1999). Naturally Occurring Mutations within 39 Amino Acids in the Envelope Glycoprotein of Maedi-Visna Virus Alter the Neutralization Phenotype. J. Virol. 73: 8064-8072 [Abstract] [Full Text]  
• Spenlehauer, C., Saragosti, S., Fleury, H. J. A., Kirn, A., Aubertin, A.-M., Moog, C. (1998). Study of the V3 Loop as a Target Epitope for Antibodies Involved in the Neutralization of Primary Isolates versus T-Cell-Line-Adapted Strains of Human Immunodeficiency Virus Type 1. J. Virol. 72: 9855-9864 [Abstract] [Full Text]